Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New inhibitors of G12C mutant KRAS protein identified at Amgen

May 16, 2022

Chinese researchers disclose new CDK9 inhibitors

May 13, 2022

U.S. researchers describe new PROTACs for cancer

May 13, 2022

Novel Fanconi anemia xenograft murine model to test immunotherapy

May 13, 2022

CRB-601 shows promising antitumor activity alone or in combination with immunotherapy

May 12, 2022

Targeting bromodomain in Brg-1 unveiled as a promising approach for uveal melanoma

May 12, 2022

New PROTACs presented by C4 Therapeutics

May 12, 2022

Kumquat Biosciences patents SOS1/KRAS interaction inhibitors

May 12, 2022

MALT1 promotes glioblastoma pathogenesis and emerges as a potential therapeutic target

May 11, 2022

Targeting BCL10-MALT1 interaction blocks ABC-DLBCL xenograft tumor growth

May 11, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...